Last reviewed · How we verify
UHE-103 Cream
At a glance
| Generic name | UHE-103 Cream |
|---|---|
| Sponsor | Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis (PHASE1)
- A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- UHE-103 Cream CI brief — competitive landscape report
- UHE-103 Cream updates RSS · CI watch RSS
- Therapeutics, Inc. portfolio CI